Literature DB >> 10720111

Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors.

L Agréus1, N J Talley, K Svärdsudd, G Tibblin, M P Jones.   

Abstract

BACKGROUND: The utility of current diagnostic criteria for dyspepsia and irritable bowel syndrome (IBS) in clinical practice is largely unknown. We aimed to compare the diagnostic value of different definitions and questionnaires in a population.
METHODS: The Abdominal Symptom Questionnaire (ASQ) was mailed to a representative sample (n = 1506, 20-87 years old), and every fifth person (n = 302) concomitantly received the Bowel Disease Questionnaire (BDQ). The diagnostic agreement for dyspepsia and for IBS, defined in accordance with the Manning and the modified Rome criteria and a new simple definition, was analysed.
RESULTS: In the ASQ the agreement on the IBS status for the three IBS definitions was > or = 88%, and in the BDQ > or = 93%. Agreement for the three definitions on the two questionnaires was > or = 88% regardless of which definition of IBS was applied. Agreement between questionnaires was similar (88%) for dyspepsia. For both IBS and dyspepsia the kappa coefficients indicated moderate to substantial concordance. 'Pain or discomfort' did not cover all linguistic aspects of dyspepsia. Prevalence rates of dyspepsia were comparable in the ASQ and BSQ, whereas higher prevalences of IBS with the ASQ was related to the cutoff levels for reporting abdominal pain or discomfort.
CONCLUSION: It is possible to identify IBS more simply by self-report questionnaires.

Entities:  

Mesh:

Year:  2000        PMID: 10720111     DOI: 10.1080/003655200750024308

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

1.  Best practice in symptom assessment: a review.

Authors:  E McColl
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.

Authors:  Anita Sainsbury; Alexander C Ford
Journal:  Therap Adv Gastroenterol       Date:  2011-03       Impact factor: 4.409

Review 4.  Epidemiology of functional dyspepsia: a global perspective.

Authors:  Sanjiv Mahadeva; Khean-Lee Goh
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 5.  Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.

Authors:  Alexander C Ford; Nicholas J Talley
Journal:  J Gastroenterol       Date:  2011-02-18       Impact factor: 7.527

6.  Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study.

Authors:  P Aro; J Ronkainen; N J Talley; T Storskrubb; E Bolling-Sternevald; L Agréus
Journal:  Gut       Date:  2005-05-25       Impact factor: 23.059

7.  Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study).

Authors:  Pertti Aro; Jukka Ronkainen; Tom Storskrubb; Michael Vieth; Lars Engstrand; Sven-Erik Johansson; Elisabeth Bolling-Sternevald; Gunilla Bolinder; Kjell Alving; Nicholas J Talley; Lars Agréus
Journal:  Eur J Epidemiol       Date:  2010-07-29       Impact factor: 8.082

8.  Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia.

Authors:  M M Walker; N J Talley; M Prabhakar; C J Pennaneac'h; P Aro; J Ronkainen; T Storskrubb; W S Harmsen; A R Zinsmeister; L Agreus
Journal:  Aliment Pharmacol Ther       Date:  2009-01-17       Impact factor: 8.171

9.  Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters.

Authors:  S Haag; N J Talley; G Holtmann
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 10.  Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.

Authors:  Alexander C Ford; Nicholas J Talley; Brennan M R Spiegel; Amy E Foxx-Orenstein; Lawrence Schiller; Eamonn M M Quigley; Paul Moayyedi
Journal:  BMJ       Date:  2008-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.